A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
DUBLIN, Ireland, Nov. 17, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. Quarter 3 Results...
Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERNDUBLIN, Oct. 29, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...
DUBLIN, Ireland, Aug. 25, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020. Quarter 2 Results...
DUBLIN, Ireland, Aug. 20, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets announced that it has filed its submission for an Emergency Use Authorization (EUA)...
Conference Call Scheduled for August 25, 2020 at 11:00am EASTERNDUBLIN, Ireland, Aug. 18, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...
DUBLIN, Ireland, Aug. 17, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced that its subsidiary Primus Corporation has received a warning letter from...
DUBLIN, Ireland, May 27, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2020. Quarter 1 Results...
Conference Call Scheduled for May 27, 2020 at 11:00am EASTERNDUBLIN, Ireland, May 14, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial...
DUBLIN, Ireland, March 31, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2019 and fiscal year...
Conference Call Scheduled for March 31, 2020 at 11:00am EASTERNDUBLIN, Ireland, March 24, 2020 -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report...